Regulation of CD8 T cell effector function by NFKBID 9358

Abstract Description Chronic antigen exposure imposes a state of hypo-responsiveness called T cell exhaustion. Exhaustion is characterized as enhanced expression of inhibitory receptors, decreased expression of cytokines, decreased proliferation as well as decreased cytotoxicity. Cancers further exacerbate inadequate anti-tumor immunity by fostering a metabolically hostile microenvironment which hampers T cell survival. My research in the Hogan lab is focused on arming T cells to mount effective anti-tumor responses by overcoming exhaustion, and increasing T cell numbers in the face of rapidly growing tumors by enhancing T cell proliferation and survival. I have demonstrated that overexpression of the 50kD isoform of NFKBID, an IkB factor that regulates NF-κB transcriptional activity, enhances T cell expansion and short-lived effector functions in melanoma, reducing the rate of tumor growth, and extending the survival of tumor bearing mice. Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2025-11-01
DOI
https://doi.org/10.1093/jimmun/vkaf283.2769
Primary Topic
NF-κB Signaling Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Regulation of CD8 T cell effector function by NFKBID 9358

Patrick G. Hogan, Barsha Dash
The Journal of Immunology
NF-κB Signaling Pathways
article

Regulation of CD8 T cell effector function by NFKBID 9358

Patrick G. Hogan, Barsha Dash
article en

Abstract

Abstract Description Chronic antigen exposure imposes a state of hypo-responsiveness called T cell exhaustion. Exhaustion is characterized as enhanced expression of inhibitory receptors, decreased expression of cytokines, decreased proliferation as well as decreased cytotoxicity. Cancers further exacerbate inadequate anti-tumor immunity by fostering a metabolically hostile microenvironment which hampers T cell survival. My research in the Hogan lab is focused on arming T cells to mount effective anti-tumor responses by overcoming exhaustion, and increasing T cell numbers in the face of rapidly growing tumors by enhancing T cell proliferation and survival. I have demonstrated that overexpression of the 50kD isoform of NFKBID, an IkB factor that regulates NF-κB transcriptional activity, enhances T cell expansion and short-lived effector functions in melanoma, reducing the rate of tumor growth, and extending the survival of tumor bearing mice. Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)

The Journal of ImmunologyVol. 214(Supplement_1)
La Jolla Institute for Immunology (US), UC San Diego Health System (US)
Openalex Percentile: Top 57%
NF-κB Signaling Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.